Antioxidant Biomolecules and Their Potential for the Treatment of Difficult-to-Treat Depression and Conventional Treatment-Resistant Depression
Major depression is a devastating disease affecting an increasing number of people from a young age worldwide, a situation that is expected to be worsened by the COVID-19 pandemic. New approaches for the treatment of this disease are urgently needed since available treatments are not effective for a...
Saved in:
Main Authors: | María Eugenia Riveros (Author), Alba Ávila (Author), Koen Schruers (Author), Fernando Ezquer (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
#TreatmentResistantDepression: A qualitative content analysis of Tweets about difficult‐to‐treat depression
by: Amelia Talbot, et al.
Published: (2023) -
Oxidative Stress and Neuroinflammation as a Pivot in Drug Abuse. A Focus on the Therapeutic Potential of Antioxidant and Anti-Inflammatory Agents and Biomolecules
by: Pablo Berríos-Cárcamo, et al.
Published: (2020) -
Treatment resistant depression in women with peripartum depression
by: M. Soledad Cepeda, et al.
Published: (2019) -
New Biomolecules and Drug Delivery Systems as Alternatives to Conventional Antibiotics
Published: (2022) -
New Biomolecules and Drug Delivery Systems as Alternatives to Conventional Antibiotics
by: Helena P. Felgueiras
Published: (2022)